bivalirudin
Drug Details
- Generic Name
- bivalirudin
- Brand Names
- Bivalirudin, bivalirudin
- Application Number
- ANDA210031
- Sponsor
- Ambiopharm, Inc.
- NDC Codes
- 8
- Dosage Forms
- POWDER, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Routes
- INTRAVENOUS
- Active Ingredients
- BIVALIRUDIN
Indications and Usage
1 INDICATIONS AND USAGE Bivalirudin for injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Bivalirudin for injection is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS). ( 1 )